Acetaminophen Market Analysis

  • Report ID: 6190
  • Published Date: Sep 17, 2025
  • Report Format: PDF, PPT

Acetaminophen Market Segmentation:

Dosage Form Segment Analysis  

Tablets segment is estimated to dominate over 57% acetaminophen market share by 2035. More than 90 million high-temperate cases occur per week, requiring the administering of acetaminophen. Acetaminophen tablets are also preferred in patients with peptic ulcers, and those who cannot tolerate aspirin. Despite having high absorption properties, one would have to consume high-dose acetaminophen for an extended period of time before the first side effect appears. Since the system efficiently absorbs it in a span of 60 minutes, tablet routes are preferred over liquid suspension, or IV due to its affordability and convenience. Also, administering acetaminophen through the oral route is noted to have the least amount of side effects.

Route of Administration Segment Analysis  

By 2035, oral segment is poised to dominate over 33% acetaminophen market share. Acetaminophen is administered to both in-patient and outpatient patients, with dosage depending upon the age and weight of the individual.  The parenteral dosage is preferred among patients suffering from severe nausea. Fevers are the most common occurrence and in its treatment, acetaminophen is administered in combination with other viral medications. The pandemic caused by COVID-19 also shot up the demand for oral acetaminophen in the global market, even leading to instances of shortage. Also, used in pain relief, 1 in 10 people suffer from chronic pain, requiring the administering of acetaminophen combination drugs 

Application (Common Cold, Pain Relief)

In acetaminophen market, common-cold segment is anticipated to dominate over 30% revenue share by 2035. On average, a person gets symptoms of the common cold, 4-6 times a year. There are no treatments for viral infections like the common cold. The only approach is to tend to the symptoms like headache, stuffed nose, and body aches, for which acetaminophen is prescribed, through various routes of administration. An average adult is said to experience cold symptoms at least 3 times a year. Acetaminophen finds its most application in these cases. It is also found in combination with other drugs in allergy medications, sleep medications, etc.

Our in-depth analysis of the global acetaminophen market includes the following segments:

         Dosage Form

  • Tablets

  • Liquid Suspension

         Route of Administration

  • Oral

  • Parenteral

         Application

  • Common Cold

  • Pain Relief

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of acetaminophen is assessed at USD 11.26 billion.

The global acetaminophen market size surpassed USD 10.85 billion in 2025 and is projected to grow at a CAGR of more than 4.2%, reaching USD 16.37 billion revenue by 2035.

North America acetaminophen market will hold more than 37% share by 2035, driven by robust healthcare infrastructure and rising demand due to chronic pain and illnesses.

Key players in the market include Mallinckrodt Pharmaceuticals, Johnson & Johnson, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V. (Viatris), Perrigo Company plc, Zydus Cadila, Aurobindo Pharma Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos